Skip to main content
. 2022 Jul 5;43(1):97–108. doi: 10.1093/asj/sjac179

Table 5.

Adverse Events Experienced by >3% of Participants

Adverse event No. (%)
Ecchymosis 59 (86.8)
Tenderness 35 (51.5)
Pain 26 (38.2)
Induration 24 (35.3)
Numbness 11 (16.2)
Incision-site bleeding 11 (16.2)
Edema 8 (11.8)
Fluid discharge 6 (8.8)
Hemosiderin stain 5 (7.4)
Swelling 4 (5.8)
Burning sensation 3 (4.4)
Tingling 3 (4.4)